FDA Inspection 997990 — Randolph Health
The FDA completed an inspection of Randolph Health on January 19, 2017 in Asheboro, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 19, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Asheboro, NC (United States)